Prognia
Drug Database
🇪🇺EU · EMAWithdrawn

Acticam(meloxicam)

Marketing Authorisation Holder: Ecuphar

EMA Authorisation: 09/12/2008

INN: meloxicam

Indication

Oral suspension: Dogs: Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders. Solution for injection: Dogs: Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders. Reduction of postoperative pain and inflammation following orthopaedic and soft-tissue surgery. Cats: Reduction of postoperative pain after ovariohysterectomy and minor soft-tissue surgery.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Acticam — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.